A month into its COVID-19 vaccine rollout, Zimbabwe has struggled to surpass the 75,000 mark as some front-line health workers are skeptical about the Chinese-made Sinopharm efficacy rate.
China’s ‘vaccine diplomacy’ fills void in developing world left by US ‘vaccine nationalism’